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The association of coeliac disease and inflammatory bowel disease is rare, as only three individual cases have been reported. The first report concerned a patient with established coeliac disease who eventually developed Crohn's disease,' the second was a patient with Crohn's disease and severe growth retardation who was later found to have coeliac disease,2 and the third was a patient with ulcerative colitis and coeliac disease associated with selective immunoglobulin A deficiency.3 Salem and his colleages4 described a patient with ulcerative colitis and a flat jejunal biopsy and similar changes in a second patient.5 Other authors have accepted that both these patients have coeliac disease and inflammatory bowel disease and thus might constitute two additional examples of the association." This paper describes four patients who had coexistent coeliac disease and inflammatory bowel disease. Three patients had ulcerative colitis and the other Crohn's disease. The prevalence rates of the two disorders have been examined to assess the significance of the association.
Case reports (Table) CASE 1 J S, who was born on 13 December 1944, presented in August 1975 with a six month history of diarrhoea, discomfort in the left iliac fossa, and intermittent rectal bleeding. He had not travelled abroad. Physical examination was normal. Investigations showed haemoglobin 12 g/dl, serum albumin 41 g/l, serum seromucoids 098 g/l (normal <1 50 g/l). Sigmoidoscopy revealed perianal skin tags, and an abnormal rectal mucosa with contact bleeding. Infiltration of the lamina propria by polymorpho- ng/l (normal range 200-800 ng/l). Serum albumin 41 g/l, serum seromucoid 2.20 g/l. Radiological examination of the small intestine showed dilated loops and a slow transit time suggestive of malabsorption ( Fig. 1) . Jejunal biopsy showed a flat mucosa (Fig. 2a) . His symptoms persisted despite adhering to a strict gluten free diet.
Further radiological examination of the large intestine in January 1977 showed multiple aphthoid ulcers in the descending and sigmoid colon with rectal sparing (Fig. 3 granular rectal mucosa with contact bleeding. Rectal biopsy showed an active proctitis (Fig. 4) (Fig. 6b) .
He was admitted in May 1972 with a six month history of diarrhoea and rectal bleeding. Physical examination was normal. Investigations showed haemoglobin 10.6 g/dl, serum iron 6 timol/l, serum folate 3 sig/l, serum B12 130 ng/l, serum albumin 33 g/l, serum seromucoids 2.10g/l. Radiological examination of the large intestine demonstrated an abnormal mucosal pattern in the descending and sigmoid colon with rectal involvement (Fig. 7) DE, born 7 June 1914, presented in 1946 with a microcytic hypochromic anaemia which was treated with iron supplements. Three years later she was admitted to hospital with a four week history of diarrhoea and rectal bleeding. On close questioning she admitted to intermittent episodes of diarrhoea for four years. The stool was pale, watery, and offensive. She had a smooth tongue but physical examination was otherwise normal. Investigations showed haemoglobin 5.5 g/dl, microcytic hypochromic blood film, serum albumin 31 g/l, serum seromucoids 21 g/l; faecal fat excretion was 31 mmol/24 hours. Stool microscopy and culture was, negative. Radiological examination of the small intestine revealed distended loops in the distal ileum and a barium enema examination showed features of ulcerative colitis. She was treated with bed rest, blood transfusion, and iron supplements with symptomatic improvement. She was readmitted in 1951 with severe diarrhoea having six to 10 watery bowel actions per day. The stool contained blood and mucus. On physical examination she was tender in the right iliac fossa with erythema nodosum in both legs. Investigations showed haemoblogin 5.3 g/dl, with an iron deficiency picture. Faecal fat excretion was 53-70 mmol/24 hours. Radiological examination showed dilated loops throughout the small intestine with abnormal mucosal pattern. Radiological examination of the large intestine revealed a left-sided ulcerative colitis. She was readmitted on three other occasions between 1952 and 1955 and on the last occasion remission was induced by oral cortisone therapy.
She was readmitted in July 1967 with a short history of diarrhoea, rectal bleeding, and weight loss. On physical examination she was thin with marked hepatomegaly. An ulcerated polypoid rectal mass was seen on sigmoidoscopy which histologically was an adenocarcinoma. She deteriorated rapidly and died two months later. Necropsy confirmed that she had a total colitis with an ulcerated polypoid carcinoma 9 cm in diameter in the upper rectum. Metastases were found in both the adjacent lymph nodes and liver. Dissecting microscopy and histological examination of the whole length of the small intestine revealed a flat mucosa over 75 cm of the proximal jejunum with convolutions in the distal jejunum and ileum and digitate villi in the terminal ileum.
Discussion
Coeliac disease was diagnosed on the basis of a flat jejunal mucosa. Our reasons for adopting a less restrictive definition of the disorder than others have been fully discussed elsewhere.' In addition, three of the four cases showed a morphological response to a gluten free diet.
The prevalence of inflammatory bowel disease varies between 96-190 per 100 000 cases.8 Thus in a population of 420 patients with coelic disease the expected number of patients with inflammatory bowel disease would range from 0-4-0.8 cases. The observed prevalence in this series was four cases, which is five to 10 times the expected prevalence.
The prevalence of coeliac disease is uncertain; we have used the estimated prevalence of 1 in 1800 in the general population in Great Britain.9 This study was not entirely satisfactory, for it was.
calculated from the mean annual number of cases diagnosed in the Royal Hospital for Sick Children, Glasgow, in the years 1948 to 1960 before intestinal biopsy was commonly undertaken and related to indirect estimates of the population served by the hospital. Using this prevalence figure the expected number of patients with coeliac disease among our 1240 patients with inflammatory bowel disease would thus be 0-69 cases. The observed prevalence in this series was four cases, which is nearly six times the expected prevalence, but this figure must be interpreted with caution.
Taken together, these figures suggest that the two disorders may coexist more commonly than would be expected by chance.
It must also be emphasised that these patients have been subject to extensive investigation in a unit with particular interest in both disorders. The principal object of describing this association is to encourage the identification of additional examples.
We have recently drawn attention to the frequency of immunological disorders associated with coeliac disease10 confirming the hypothesis put forward by Scott and Losowsky6 based on their review of the literature. Such an immunological disorder in coeliac disease could predispose the individual to inflammatory bowel disease because of the transfer of antigenic material across the damaged small intestinal mucosa.
Alternatively, if the hypothesis that inflammatory bowel disease is of viral aetiology proves to be correct then the presence of coeliac disease-and thus an altered immune response-might render the individual more susceptible to infection.
As both disorders usually present with gastrointestinal symptoms the possibility that they coexist can readily be overlooked. Such an association should be considered in the patient who is not showing the expected response to treatment or where there are unusual clinical features.
